BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22844088)

  • 1. Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.
    Peacey E; Rodriguez L; Liu Y; Wolfe MS
    Nucleic Acids Res; 2012 Oct; 40(19):9836-49. PubMed ID: 22844088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
    Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure.
    Liu Y; Rodriguez L; Wolfe MS
    Bioorg Chem; 2014 Jun; 54():7-11. PubMed ID: 24691171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.
    Jiang Z; Cote J; Kwon JM; Goate AM; Wu JY
    Mol Cell Biol; 2000 Jun; 20(11):4036-48. PubMed ID: 10805746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kalbfuss B; Mabon SA; Misteli T
    J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveying cis-acting sequences of pre-mRNA by adding antisense 2'-O-methyl oligoribonucleotides to a splicing reaction.
    Mayeda A; Hayase Y; Inoue H; Ohtsuka E; Ohshima Y
    J Biochem; 1990 Sep; 108(3):399-405. PubMed ID: 2277033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone).
    Zheng S; Chen Y; Donahue CP; Wolfe MS; Varani G
    Chem Biol; 2009 May; 16(5):557-66. PubMed ID: 19477420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing.
    Donahue CP; Muratore C; Wu JY; Kosik KS; Wolfe MS
    J Biol Chem; 2006 Aug; 281(33):23302-6. PubMed ID: 16782711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry.
    Xing S; Wang J; Wu R; Hefti MM; Crary JF; Lu Y
    RNA Biol; 2022; 19(1):104-116. PubMed ID: 34965173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.
    Arechavala-Gomeza V; Graham IR; Popplewell LJ; Adams AM; Aartsma-Rus A; Kinali M; Morgan JE; van Deutekom JC; Wilton SD; Dickson G; Muntoni F
    Hum Gene Ther; 2007 Sep; 18(9):798-810. PubMed ID: 17767400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
    Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
    Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
    Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
    J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sites.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2002 Jul; 277(29):26587-99. PubMed ID: 12000767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
    Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
    Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.
    Chen JL; Moss WN; Spencer A; Zhang P; Childs-Disney JL; Disney MD
    PLoS One; 2019; 14(7):e0219210. PubMed ID: 31291322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2000 Jun; 275(23):17700-9. PubMed ID: 10748133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.